F-1 EX-FILING FEES 0001912966 N/A N/A 0001912966 1 2026-07-01 2026-07-01 0001912966 2026-07-01 2026-07-01 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

F-1

REGENTIS BIOMATERIALS LTD.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Ordinary shares, no par value per share   (1)   Other   3,807,143   $ 4.2850   $ 16,313,607.76   0.0001381   $ 2,252.91
                                           
Total Offering Amounts:   $ 16,313,607.76         2,252.91
Total Fees Previously Paid:                
Total Fee Offsets:                
Net Fee Due:             $ 2,252.91

__________________________________________
Offering Note(s)

(1) Pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Registrant is also registering hereunder an indeterminate number of additional ordinary shares that shall be issuable pursuant to Rule 416 to prevent dilution resulting from stock splits, stock dividends or similar transactions.

Consists of (i) 1,844,543 ordinary shares issued in a private placement on June 17, 2026 (the “Private Placement”), (ii) 12,600 ordinary shares issuable upon the exercise of pre-funded warrants issued in the Private Placement, (iii) 1,857,143 ordinary shares issuable upon the exercise of ordinary warrants issued in the Private Placement and (iv) 92,857 ordinary shares issuable upon the exercise of placement agent warrants issued in the Private Placement to the placement agent as compensation for its services in connection with the Private Placement.

All 3,807,143 ordinary shares are to be offered for resale by the selling shareholders named in the prospectus contained in this Registration Statement on Form F-1.

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s ordinary shares on the Nasdaq Capital Market on July 2, 2026.

The Registrant will not receive any proceeds from the sale of its ordinary shares by the selling shareholder.